SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-413406
Filing Date
2014-11-14
Accepted
2014-11-14 16:57:51
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d806425d10q.htm 10-Q 587745
2 EX-31.1 d806425dex311.htm EX-31.1 6671
3 EX-31.2 d806425dex312.htm EX-31.2 6662
4 EX-32.1 d806425dex321.htm EX-32.1 6714
  Complete submission text file 0001193125-14-413406.txt   4440472

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ck0001478069-20140930.xml EX-101.INS 563276
6 XBRL TAXONOMY EXTENSION SCHEMA ck0001478069-20140930.xsd EX-101.SCH 49810
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001478069-20140930_cal.xml EX-101.CAL 55222
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001478069-20140930_def.xml EX-101.DEF 186157
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001478069-20140930_lab.xml EX-101.LAB 372511
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001478069-20140930_pre.xml EX-101.PRE 281404
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 141225172
SIC: 2834 Pharmaceutical Preparations